L. Barker

Insider Reports History

Entity
Individual
Location
51 Aunt Molly Road, Hopewell, NJ
Signature
/s/ Samuel L. Barker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by L. Barker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. Director Common Stock 87.6K $230K $2.62 Apr 28, 2024 Direct
Cyclacel Pharmaceuticals, Inc. Director Common Stock 40.4K $134K $3.32 Jun 30, 2023 Direct
LEXICON PHARMACEUTICALS, INC. Director Restricted Stock Units 36.8K $96.4K $2.62 May 13, 2024 Direct
LEXICON PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 44.9K May 13, 2024 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 42.4K Jun 30, 2023 Direct

Insider Reports Filed by L. Barker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXRX LEXICON PHARMACEUTICALS, INC. May 13, 2024 2 $0 4 May 13, 2024 Director
LXRX LEXICON PHARMACEUTICALS, INC. Apr 28, 2024 2 $0 4 Apr 29, 2024 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 30, 2023 2 $0 4 Jul 3, 2023 Director
LXRX LEXICON PHARMACEUTICALS, INC. May 21, 2023 2 $0 4 May 22, 2023 Director
LXRX LEXICON PHARMACEUTICALS, INC. Apr 28, 2023 2 $0 4 Apr 28, 2023 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
LXRX LEXICON PHARMACEUTICALS, INC. May 21, 2022 2 $0 4 May 23, 2022 Director
LXRX LEXICON PHARMACEUTICALS, INC. Apr 30, 2022 2 $0 4 May 2, 2022 Director
CYCC Cyclacel Pharmaceuticals, Inc. Nov 30, 2021 1 -$43 4 Dec 2, 2021 Director
CYCC Cyclacel Pharmaceuticals, Inc. Aug 24, 2021 1 $5K 4 Aug 25, 2021 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 15, 2021 2 $0 4 Jun 17, 2021 Director